Tour de France champion Froome asked to explain drug test

The UCI has requested information from Vuelta a Espana winner Chris Froome due to an excessive salbutamol reading in a drugs test.

A urine sample supplied by Froome on September 7, following stage 18 of the Vuelta a Espana, showed a concentration of the substance that was double the World Anti-Doping Agency (WADA) threshold of 1,000 nanograms per millilitre.   -  Getty Images

Tour de France champion Chris Froome has been asked by the UCI to explain elevated levels of salbutamol in a drugs test at the competition.

A urine sample supplied by Froome on September 7, following stage 18 of the Vuelta a Espana, showed a concentration of the substance that was double the World Anti-Doping Agency (WADA) threshold of 1,000 nanograms per millilitre.

Asthma medication salbutamol is permitted by WADA rules without the need for a therapeutic use exemption (TUE) when inhaled up to a certain level over 24 hours, and the adverse finding, confirmed through a test of the 32-year-old's sample, does not necessarily constitute a break of the rules and Froome will not be hit with a provisional suspension.

According to Team Sky, the UCI's request for further information is to "ensure that no more than the permissible doses of salbutamol were inhaled".

For more updates, follow Sportstar on :